13D/13G Filings - Ampersand 2018 Limited Partnership

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-16
4:30 pm
Purchase
2024-10-1113DInterpace Biosciences, Inc.
IDXG
Ampersand 2018 Limited Partnership13,861,386
76.000%
9,194,720increase
(+197.03%)
Filing
History
2021-11-12
4:31 pm
Unchanged
2021-11-0113DInterpace Biosciences, Inc.
IDXG
Ampersand 2018 Limited Partnership4,666,666
38.900%
0
(Unchanged)
Filing
History
2021-05-18
5:01 pm
Unchanged
2021-05-1013DInterpace Biosciences, Inc.
IDXG
Ampersand 2018 Limited Partnership4,666,666
39.100%
0
(Unchanged)
Filing
History
2021-01-19
4:13 pm
Unchanged
2021-01-0713DInterpace Biosciences, Inc.
IDXG
Ampersand 2018 Limited Partnership4,666,666
39.300%
0
(Unchanged)
Filing
History
2020-04-22
5:40 pm
Unchanged
2020-04-0713DInterpace Biosciences, Inc.
IDXG
Ampersand 2018 Limited Partnership4,666,666
39.300%
0
(Unchanged)
Filing
History